Mental Retardation Clinical Trials

5 recruiting

Mental Retardation Trials at a Glance

9 actively recruiting trials for mental retardation are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Shanghai, New York, and Istanbul. Lead sponsors running mental retardation studies include Icahn School of Medicine at Mount Sinai, Shanghai Mental Health Center, and Inonu University.

Browse mental retardation trials by phase

Treatments under study

About Mental Retardation Clinical Trials

Looking for clinical trials for Mental Retardation? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mental Retardation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mental Retardation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Magnetoencephalography in Children

EpilepsyAutismCerebrovascular Disease+6 more
Children's Hospital of Fudan University1,500 enrolled1 locationNCT06668519
Recruiting
Not Applicable

Physical Activity and Community EmPOWERment Project

Williams SyndromeWAGR SyndromePrader-Willi Syndrome+10 more
University of North Carolina, Chapel Hill376 enrolled2 locationsNCT06740162
Recruiting
Not Applicable

Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents

SchizophreniaSevere Mental DisorderSchizoaffective Disorder+4 more
Shanghai Mental Health Center82 enrolled1 locationNCT06904079
Recruiting
Not Applicable

Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation

Mental Retardation
Istanbul University - Cerrahpasa33 enrolled1 locationNCT07028333
Recruiting

The Relationship Between Hand Grip Strength, Trunk Control and Functional Performance in Individuals With Mild Mental Retardation

Mental Retardation
Inonu University50 enrolled1 locationNCT06934850
Recruiting

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Autism Spectrum DisorderFOXP1Mental Retardation With Language Impairment and With or Without Autistic Features
Icahn School of Medicine at Mount Sinai50 enrolled1 locationNCT03718923
Recruiting

Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models

Cerebral PalsyAttention Deficit Hyperactivity DisorderMental Retardation+2 more
Yun Liu,PhD2,000 enrolled1 locationNCT06848959
Recruiting

A Study on the Preference of Risperidone Dosage Forms

SchizophreniaAutism Spectrum DisorderMental Retardation+2 more
Shanghai Mental Health Center1,000 enrolled1 locationNCT06657430
Recruiting

DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Autism Spectrum DisorderDDX3XMental Retardation, X-linked 102
Icahn School of Medicine at Mount Sinai10 enrolled1 locationNCT03718910